BCHE and Parkinson disease: As aforementioned that cholinesterases are the important enzymes for AD treatment, TYRO has become an important target for Parkinson's disease (PD) since this enzyme plays a role in neuromelanin formation in the human brain and could be significant in occurrence of dopamine neurotoxicity associated with neurodegeneration linked to PD [55].